Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Zealand teams with Protagonist for peptide drug discovery/development

Executive Summary

Danish biotech Zealand Pharma AS (cardiovascular, metabolic, and gastrointestinal disorders) will collaborate with fellow peptide drug developer Protagonist Therapeutics Inc. on the discovery and development of novel disulfide-rich peptide (DRP) candidates across various therapeutic areas that Zealand Pharma has already identified.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Intra-Biotech Deal

Related Companies

Advertisement
UsernamePublicRestriction

Register